Dr Robert DeBernardo explains how new immunotherapies are reshaping care and how their earlier availability might have ...

The European Commission has approved a combination of an immunotherapy agent with a poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of certain patients with primary advanced or ...

What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...

Despite available treatments, incidence and mortality rates for endometrial cancer, the most common type of uterine cancer, have increased. 1,2 One factor that’s behind this trend: weight gain. "Our ...

Stage 2 endometrial cancer spreads to the cervical stroma but remains within the uterus and cervix, requiring precise staging and diagnosis. Treatment typically involves surgery, possibly a radical ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

Increased endometrial thickness is a potential sign of endometrial cancer. Doctors are most likely to be concerned if you also experience bleeding. Endometrial thickness refers to the thickness of the ...

—A new study from California-based researchers reports that things may be getting worse for certain women at risk for endometrial cancer. Here’s what the research team adds to what’s known about ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Metastatic endometrial cancer can affect distant areas of the body, such as the lungs, liver, bones, or brain. Treatments may include surgery alongside radiation therapy, chemotherapy, or other drugs.